This is a medical urgency that requires same-day evaluation
There may be no discernible mammographic changes even in cases of significant weight loss while on GLP-1 agonists
This side effect was more noticeable in patients who received the GLP-1RA treatment off-label, as a weight-loss medication
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1 receptor agonists, including Ozempic, Semaglutide, and Rybelsus, have surged over the last five years as their effectiveness in promoting weight loss gains attention beyond type 2 diabetes care
GLP-1 receptor agonists, while effective, come with drawbacks, and they also require long-term use, which can be costly and may not address the root causes of obesity